Palvella Therapeutics, Inc. Shares Outstanding
Palvella Therapeutics, Inc. (PVLA) had Shares Outstanding of 14.40 million shares as of 2026-06-30, per its 10-Q filed 2026-08-04.
Prices
us-gaap:CommonStockSharesOutstanding · last filed 2026-08-04
- 2026-06-30: Shares outstanding (split-adjusted) 14.40M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2026-03-31: Shares outstanding (split-adjusted) 14.31M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-12-31: Shares outstanding (split-adjusted) 12.38M shares; Shares authorized (split-adjusted) 200.00M shares.
- 2025-09-30: Shares outstanding (split-adjusted) 11.09M shares; Shares authorized (split-adjusted) 200.00M shares.
| Period end | Shares outstanding (split-adjusted) | Shares authorized (split-adjusted) |
|---|---|---|
| 2026-06-30 | 14.40M shares 10-Q · filed 2026-08-04 | 200.00M shares 10-Q · filed 2026-08-04 |
| 2026-03-31 | 14.31M shares 10-Q · filed 2026-05-07 | 200.00M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 12.38M shares 10-Q · filed 2026-08-04 | 200.00M shares 10-Q · filed 2026-08-04 |
| 2025-09-30 | 11.09M shares 10-Q · filed 2025-11-12 | 200.00M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 11.06M shares 10-Q · filed 2025-08-14 | 200.00M shares 10-Q · filed 2025-08-14 |
| 2025-03-31 | 11.02M shares 10-Q · filed 2025-05-15 | 200.00M shares 10-Q · filed 2025-05-15 |
| 2024-12-31 | 11.01M shares 10-K · filed 2026-03-31 | 200.00M shares 10-K · filed 2026-03-31 |
| 2024-09-30 | 1.32M shares 10-Q · filed 2024-11-13 | 3.75M shares 10-Q · filed 2024-11-13 |
| 2024-06-30 | 1.32M shares 10-Q · filed 2024-08-14 | 3.75M shares 10-Q · filed 2024-08-14 |
| 2024-03-31 | 1.24M shares 10-Q · filed 2024-05-15 | 3.75M shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 1.77M shares 10-K · filed 2025-03-31 | 8.97M shares 10-K · filed 2025-03-31 |
| 2023-09-30 | (m) | 300.00M shares 10-Q · filed 2023-11-14 |
| 2023-06-30 | 98.85M shares 10-Q · filed 2023-11-14 | 300.00M shares 10-Q · filed 2023-08-10 |
| 2023-03-31 | 74.52M shares 10-Q · filed 2023-05-11 | 300.00M shares 10-Q · filed 2023-05-11 |
| 2022-12-31 | 74.52M shares 10-K · filed 2024-03-29 | 29.00M shares 10-K · filed 2026-03-31 |
| 2022-09-30 | 74.41M shares 10-Q · filed 2022-11-04 | 300.00M shares 10-Q · filed 2022-11-04 |
| 2022-06-30 | 74.26M shares 10-Q · filed 2022-08-04 | 300.00M shares 10-Q · filed 2022-08-04 |
| 2022-03-31 | 74.10M shares 10-Q · filed 2022-05-11 | 300.00M shares 10-Q · filed 2022-05-11 |
| 2021-12-31 | 72.22M shares 10-K · filed 2023-03-31 | 300.00M shares 10-K · filed 2023-03-31 |
| 2021-09-30 | 71.50M shares 10-Q · filed 2021-11-02 | 300.00M shares 10-Q · filed 2021-11-02 |
| 2021-06-30 | 66.68M shares 10-Q · filed 2021-08-05 | 300.00M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 59.72M shares 10-Q · filed 2021-05-17 | 300.00M shares 10-Q · filed 2021-05-17 |
| 2020-12-31 | 56.00M shares 10-K · filed 2022-03-02 | 300.00M shares 10-K · filed 2022-03-02 |
| 2020-09-30 | 55.97M shares 10-Q · filed 2020-11-04 | 300.00M shares 10-Q · filed 2020-11-04 |
| 2020-06-30 | 52.40M shares 10-Q · filed 2020-08-10 | 300.00M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 55.21M shares 10-Q · filed 2020-05-11 | 300.00M shares 10-Q · filed 2020-05-11 |
| 2019-12-31 | 55.21M shares 10-K · filed 2021-03-31 | 300.00M shares 10-K · filed 2021-03-31 |
| 2019-09-30 | 49.39M shares 10-Q · filed 2019-11-12 | 300.00M shares 10-Q · filed 2019-11-12 |
| 2019-06-30 | 49.26M shares 10-Q · filed 2019-08-09 | 300.00M shares 10-Q · filed 2019-08-09 |
| 2019-03-31 | 49.15M shares 10-Q · filed 2019-05-10 | 300.00M shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 54.15M shares 10-K · filed 2020-03-13 | 300.00M shares 10-K · filed 2020-03-13 |
| 2018-09-30 | 54.15M shares 10-Q · filed 2018-11-07 | 300.00M shares 10-Q · filed 2018-11-07 |
| 2018-06-30 | 54.01M shares 10-Q · filed 2018-08-09 | 300.00M shares 10-Q · filed 2018-08-09 |
| 2018-03-31 | 53.97M shares 10-Q · filed 2018-05-10 | 300.00M shares 10-Q · filed 2018-05-10 |
| 2017-12-31 | 45.02M shares 10-K · filed 2019-03-18 | 300.00M shares 10-K · filed 2019-03-18 |
| 2017-09-30 | 44.70M shares 10-Q · filed 2017-11-13 | 300.00M shares 10-Q · filed 2017-11-13 |
| 2017-06-30 | 43.84M shares 10-Q · filed 2017-08-11 | 300.00M shares 10-Q · filed 2017-08-11 |
| 2017-03-31 | 43.06M shares 10-Q · filed 2017-05-15 | 300.00M shares 10-Q · filed 2017-05-15 |
| 2016-12-31 | 43.06M shares 10-K · filed 2018-03-15 | 300.00M shares 10-K · filed 2018-03-15 |
| 2016-09-30 | 43.06M shares 10-Q · filed 2016-11-10 | 300.00M shares 10-Q · filed 2016-11-10 |
| 2016-06-30 | 43.06M shares 10-Q · filed 2016-08-11 | 300.00M shares 10-Q · filed 2016-08-11 |
| 2016-03-31 | 39.83M shares 10-Q · filed 2016-05-12 | 300.00M shares 10-Q · filed 2016-05-12 |
| 2015-12-31 | 39.83M shares 10-K · filed 2017-03-30 | 300.00M shares 10-K · filed 2017-03-30 |
| 2015-09-30 | 39.76M shares 10-Q · filed 2015-11-13 | 300.00M shares 10-Q · filed 2015-11-13 |
| 2015-06-30 | 29.43M shares 10-Q · filed 2015-08-13 | 300.00M shares 10-Q · filed 2015-08-13 |
| 2015-03-31 | 29.43M shares 10-Q · filed 2015-05-14 | 300.00M shares 10-Q · filed 2015-05-14 |
| 2014-12-31 | 29.28M shares 10-K · filed 2016-03-23 | 300.00M shares 10-K · filed 2016-03-23 |
| 2014-12-05 | 13.86M shares 10-K · filed 2016-03-23 | (m) |
| 2014-09-30 | 6.10M shares 10-Q · filed 2014-12-12 | 75.00M shares 10-Q · filed 2014-12-12 |
| 2014-06-30 | 6.10M shares 10-Q · filed 2014-12-12 | 75.00M shares 10-Q · filed 2014-12-12 |
| 2014-03-31 | 5.00M shares 10-Q · filed 2014-06-02 | 75.00M shares 10-Q · filed 2014-06-02 |
| 2013-12-31 | 11.83M shares 10-K · filed 2015-03-30 | 300.00M shares 10-K · filed 2015-03-30 |
| 2013-06-30 | 5.00M shares 10-K · filed 2014-09-12 | 75.00M shares 10-K · filed 2014-09-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Bausch Health Companies Inc. (BHC) | $2.113B | -1.68 | |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| OCULAR THERAPEUTIX, INC (OCUL) | United States | $2.159B | -7.15 |
| Prestige Consumer Healthcare Inc. (PBH) | United States | $2.163B | 13.03 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |